Detalhe da pesquisa
1.
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis.
Blood
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518105
2.
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL.
Blood
; 140(1): 45-57, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452517
3.
Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release.
J Immunol
; 209(9): 1724-1735, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104113
4.
Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
J Immunol
; 206(1): 225-236, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268483
5.
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.
Cell
; 134(4): 577-86, 2008 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18691745
6.
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.
Biol Chem
; 403(5-6): 545-556, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717050
7.
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.
Clin Exp Immunol
; 209(1): 22-32, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325068
8.
The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.
J Med Virol
; 94(12): 5780-5789, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945627
9.
Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-FcεRIα mAbs.
J Allergy Clin Immunol
; 147(5): 1838-1854.e4, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326804
10.
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
Cancer Sci
; 112(8): 3029-3040, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34058788
11.
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy.
Haematologica
; 106(7): 1857-1866, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499243
12.
An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts.
Blood
; 130(13): 1543-1552, 2017 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698205
13.
Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.
Haematologica
; 102(2): 381-390, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27658435
14.
A Complement-Optimized EGFR Antibody Improves Cytotoxic Functions of Polymorphonuclear Cells against Tumor Cells.
J Immunol
; 195(10): 5077-87, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475927
15.
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.
Transfus Med Hemother
; 44(5): 327-336, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070978
16.
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.
Transfus Med Hemother
; 44(5): 292-300, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070974
17.
Fc-optimized antibodies quickly pull the trigger.
Blood
; 124(22): 3180-1, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414435
18.
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.
Blood
; 134(8): 713-716, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31311816
19.
Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth
Haematologica
; 106(9): 2507-2510, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882638
20.
Monitoring and functional characterization of the lymphocytic compartment in pancreatic ductal adenocarcinoma patients.
Pancreatology
; 16(6): 1069-1079, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424476